4 hours Summit Therapeutics Stock: Sell or Hold Before Q3 Earnings?Zacks
Devoid of any marketed drug in its portfolio, investors will likely focus on SMMT’s pipeline updates when it reports third-quarter results this month.
XDevoid of any marketed drug in its portfolio, investors will likely focus on SMMT’s pipeline updates when it reports third-quarter results this month.
X